|Mr. Jonathan Stewart Murphy ACA, MBA||CEO & Exec. Director||919k||N/A||1972|
|Ms. Jayne Marie Cottam||CFO & Exec. Director||462k||N/A||1974|
|Ms. Amanda Roddy||Sr. Investment Mang.||N/A||N/A||N/A|
|Ms. Joanne Cullen||Sr. Management Accountant||N/A||N/A||N/A|
|Mr. David Purcell||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Orla Ball||Head of Legal & Company Sec.||N/A||N/A||N/A|
|Ms. Debbie Chalcraft||Group Compliance Mang.||N/A||N/A||N/A|
|Ms. Claire Rick||Head of Public Affairs||N/A||N/A||N/A|
|Ms. Francesca Harris||Marketing Mang.||N/A||N/A||N/A|
|Ms. Belinda Lewis||Head of HR||N/A||N/A||N/A|
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at Â£2,259 million.
Assura Plc’s ISS governance QualityScore as of 1 July 2021 is 1. The pillar scores are Audit: 3; Board: 2; Shareholder rights: 1; Compensation: 1.